Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant

Journal of Infectious Diseases

Volumn 196, Issue 3, 2007, Pages 485-492

  Tramsen, Lars ^a   Beck, Olaf ^a   Schuster, Friedhelm R ^b,c   Hunfeld, Klaus Peter ^a   Latgé, Jean Paul ^d   Sarfati, Jacqueline ^d   Röger, Frauke ^a   Klingebiel, Thomas ^a   Koehl, Ulrike ^a   Lehrnbecher, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; FUNGUS HYPHAE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

CANDIDA ALBICANS; CANDIDIASIS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; FEASIBILITY STUDIES; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447651143     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519389     Document Type: Article

References (38)

1. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol 2002; 81:233-43.
2. Bowden RA. Fungal infection after marrow transplantation. In: Bowden RA, Ljungman P, Paya CV, eds. Transplant infections. Philadelphia: Lippincott-Raven, 1998:339-50.
3. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75.
4. Safdar A, Hanna HA, Boktour M, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 2004; 101:2859-65.
5. Roilides E, Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Med Mycol 2004; 42:1-13.
6. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1-23.
7. Huffnagle GB, Deepe GS. Innate and adaptive determinants of host susceptibility to medically important fungi. Curr Opin Microbiol 2003; 6:344-50.
8. Bacci A, Montagnoli C, Perruccio K, et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002; 168:2904-13.
9. Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99:3916-22.
10. Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996; 2:551-5.
11. Perruccio K, Tosti A, Burchielli E, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005; 106:4397-406.
12. Braedel S, Radsak M, Einsele H, et al. Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptors 2 and 4. Br J Haematol 2004; 125:392-9.
13. Campbell JD. Detection and enrichment of antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. Methods 2003; 31:150-9.
14. Becker C, Pohla H, Frankenberger B, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay. Nat Med 2001; 7:1159-62.
15. Beck O, Topp MS, Koehl U, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006; 107:2562-9.
16. Monteiro J, Hingorani R, Peroglizzi R, Apatoff B, Gregersen PK. Oligoclonality of CD8+ T cells in multiple sclerosis. Autoimmunity 1996; 23:127-38.
17. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994; 153:2807-18.
18. Simitsopoulou M, Roilides E. Evaluation of immunotherapy in invasive candidiasis: antifungal activity and cytokine expression assays. Methods Mol Med 2005; 118:161-79.
19. Gil-Lamaignere C, Roilides E, Lyman CA, et al. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury. Infect Immun 2003; 71:6472-8.
20. Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J Infect Dis 1997; 176:217-26.
21. Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 1998; 62:130-80.
22. Gomez MJ, Maras B, Barca A, La Valle R, Barra D, Cassone A. Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans. Infect Immun 2000; 68:694-701.
23. Montagnoli C, Sandini S, Bacci A, Romani L, La Valle R. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol 2004; 42:319-24.
24. Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, Lopez-Ribot JL. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics 2006; 6:6033-41.
25. Cai J, Roberts IN, Collins MD. Phylogenetic relationships among members of the ascomycetous yeast genera Brettanomyces, Debaryomyces, Dekkera, and Kluyveromyces deduced by small-subunit rRNA gene sequences. Int J Syst Bacteriol 1996; 46:542-9.
26. Bikandi J, San Millan R, Regulez P, Moragues MD, Quindos G, Ponton J. Detection of antibodies to Candida albicans germ tubes during experimental infections by different Candida species. Clin Diagn Lab Immunol 1998; 5:369-74.
27. d'Ostiani CF, Del Sero G, Bacci A, et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000; 191:1661-74.
28. Coker LA III, Mercadal CM, Rouse BT, Moore RN. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. J Leukoc Biol 1992; 51:305-6.
29. Ashman RB, Fulurija A, Papadimitriou JM. Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic candidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects. Microbiology 1999; 145:1631-40.
30. + T cells and possible participation of other local lymphocyte effectors. Infect Immun 2002; 70:4791-7.
31. Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant 2004; 10:143-55.
32. Rauser G, Einsele H, Sinzger C, et al. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004; 103:3565-72.
33. Koehne G, Smith KM, Ferguson TL, et al. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-γ production and growth of cytotoxic precursors. Blood 2002; 99:1730-40.
34. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft - versus-host disease. Int J Hematol 2003; 78:181-7.
35. Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr. Enhancement of macrophage candidacidal activity by interferon-gamma: increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 1993; 91:2596-601.
36. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 1994; 62:194-202.
37. + CTLs ex vivo. J Immunol 2002; 168:5954-8.
38. Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Comparison of interferon-γ, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999; 179:1038-41.